New approaches to managing asthma: a US perspective

References

• AbramsonMJPuyRMWeinerJMAllergen immunotherapy for asthmaCochrane Database Syst Rev20034CD001186 review14583928
   PubMedGoogle Scholar
• AlvingKJansonCNordvallLPerformance of a new hand-held device for exhaled nitric oxide measurement in adults and childrenRespir Res200676716626491
   PubMed Web of Science ®Google Scholar
• [ALA] American Lung AssociationTrends in asthma morbidity and mortalityAmerican Lung Association Epidemiology and Statistics Unit Research and Program Services2006 [online] Accessed 31 May 2007. URL: http://www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA-4604-8ADE-7F5D5E762256%7D/ASTHMA06FINAL.PDF
   Google Scholar
• [ATS] American Thoracic SocietyATS workshop proceedings: Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensateProc Am Thorac Soc200631314516565422
   PubMedGoogle Scholar
• Asmanex Twisthaler 220 mcg2006Kenilworth NJSchering Corporation package insert
   Google Scholar
• BalanagVMYunusFYangP-CJorupCEfficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthmaPulm Pharmacol Ther2005191394716009588
   PubMed Web of Science ®Google Scholar
• BarnesPJScientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEur Respir J2002191829111843317
   PubMed Web of Science ®Google Scholar
• BatemanEDSilinsVBogolubovMClinical equivalence of salmeterol/fluticasone propionate in combination (50/100 μg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthmaRespir Med2001951364611217910
   PubMed Web of Science ®Google Scholar
• BeehKMDeromEKanniessFIndacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthmaEur Respir J200729871817251236
   PubMed Web of Science ®Google Scholar
• BerryMAHargadonBShelleyMEvidence of a role of tumor necrosis factor α in refractory asthmaN Engl J Med200635469770816481637
   PubMed Web of Science ®Google Scholar
• BleeckerERYanceySWBaitingerLASalmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthmaJ Allergy Clin Immunol20061188091617030231
   PubMed Web of Science ®Google Scholar
• BleeckerERPostmaDLawranceREffect of polymorphisms in the β2-adrenergic receptor gene on response to long-acting β-agonist therapyLancet2007in press
   PubMedGoogle Scholar
• BoscoAPShrewsburySBLonghiMPharmacokinetics and tolerability of a novel submicron particle formulation of budesonide for nebulized delivery in asthma. Poster K7-A1922007Presented at the international conference of the American Thoracic SocietySan Francisco, CA, USA
   Google Scholar
• BouletL-PBatemanEDVovesRA randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthmaRespir Med200710116778617448650
   PubMed Web of Science ®Google Scholar
• BousquetJBouletLPPetersMJBudesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasoneRespir Med2007 Epub ahead of print
   Web of Science ®Google Scholar
• BuhlRCreemersJPVondraVOnce-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthmaRespir Med2003973233012693793
   PubMed Web of Science ®Google Scholar
• BusseWCorrenJLanierBQOmalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJ Allerg Clin Immunol200110818490
   PubMed Web of Science ®Google Scholar
• BüttnerCLunASplettstoesserTMonoclonal anti–interleukin-5 treatment suppresses eosinophil but not T-cell functionsEur Respir J20032179980312765424
   PubMed Web of Science ®Google Scholar
• CalamitaZSaconatoHPeláABEfficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration methodAllergy20066111627216942563
   PubMed Web of Science ®Google Scholar
• CasaleTBBusseWWKlineJNOmalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitisJ Allergy Clin Immunol20061171344016387596
   PubMed Web of Science ®Google Scholar
• ChangTWShiungY-YAnti-IgE as a mast cell-stabilizing therapeutic agentJ Allergy Clin Immunol200611712031216750976
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther2001231296131011558866
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.govSafety and tolerability of ciclesonide and formoterol fumarate inhaled once daily in patients with asthma (18 to 75 y) (BY9010/M1-506)2007a Accessed 29 June 2007 URL: http://www.clinicaltrials.gov/ct/show/NCT00314509?order=1
   Google Scholar
• ClinicalTrials.govEffects of mometasone furoate/formoterol combination versus mometasone furoate alone in persistent asthmatics (Study P04431AM1)2007b Accessed 29 June 2007 URL: http://www.clinicaltrials.gov/ct/show/NCT00381485?order=1 Accessed June 29, 2007
   Google Scholar
• ClinicalTrials.gov2007c Search: Flutiform. Accessed 29 June 2007 URL: http://www.clinicaltrials.gov/ct/search;jsessionid=B86F15C0A8AA03232A0528328EF047B5?term=flutiform
   Google Scholar
• ClinicalTrials.govA study of the safety and efficacy of tacrolimus inhalation aerosol in subjects with persistent asthma2007d Accessed 31 May 2007 URL: http://clinicaltrials.gov/ct/show/NCT00116103?order=20
   Google Scholar
• CorrenJKorenblatPEMillerCJTwelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthmaClin Ther2007298234317697902
   PubMed Web of Science ®Google Scholar
• CorryDBKheradmandFControl of allergic airway inflammation through immunomodulationJ Allergy Clin Immunol2006117S461416455347
   PubMed Web of Science ®Google Scholar
• CoxLAccelerated immunotherapy schedules: review of efficacy and safetyAnn Allergy Asthma Immunol2006971263816937741
   PubMed Web of Science ®Google Scholar
• CoxLSLinnemannDLNolteHSublingual immunotherapy: a comprehensive reviewJ Allergy Clin Immunol200611710213516675328
   PubMed Web of Science ®Google Scholar
• CromptonGA brief history of inhaled asthma therapy over the last fifty yearsPrim Care Respir J2006153263117092772
   PubMedGoogle Scholar
• DahlénBMalmströmKNizankowskaEImprovement of aspirin-intolerant asthma by montelukast, a leukotrienes antagonistAm J Respir Crit Care Med200216591411779723
   PubMed Web of Science ®Google Scholar
• DahlénBNizankowskaESzczeklikABenefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmaticsAm J Respir Crit Care Med19981571187949563738
   PubMed Web of Science ®Google Scholar
• DennisSMSharpSJVickersMRfor the Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research FrameworkRegular inhaled salbutamol and asthma control: the TRUST randomised trialLancet20003551675910905242
   PubMed Web of Science ®Google Scholar
• DorinskyPMYanceySWBaitingerLASalmeterol response is not affected by beta2-adrenergic receptor genotype in patients with persistent asthmaChest2004126722S
   Web of Science ®Google Scholar
• DowSWSchwarzeJHeathTDSystemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in miceHum Gene Ther19991019051410466624
   PubMed Web of Science ®Google Scholar
• DrazenJMIsraelEBousheyHAfor the National Heart Lung and Blood Institute’s Asthma Clinical Research NetworkComparison of regularly scheduled with as-needed use of albuterol in mild asthmaN Engl J Med199633584178778601
   PubMed Web of Science ®Google Scholar
• DucharmeFMDi SalvioFAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenCochrane Database Syst Rev20042CD00231415106175
   PubMedGoogle Scholar
• DyerMJHalpinDMSteinKInhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic reviewBMC Fam Pract200673416753053
   PubMedGoogle Scholar
• ErinEMLeakerBRNicholsonGCThe effects of a monoclonal antibody directed against tumor necrosis factor-α in asthmaAm J Respir Crit Care Med20061747536216840747
   PubMed Web of Science ®Google Scholar
• ForesiAMorelliMCCatenaEon behalf of the Italian Study GroupLow-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma controlChest2000117440610669688
   PubMed Web of Science ®Google Scholar
• GibsonPGPowellHDucharmeFLong-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and childrenCochrane Database Syst Rev20054CD00507616235393
   PubMedGoogle Scholar
• GINA (Global Initiative for Asthma)GINA report: Global Strategy for Asthma Management and Prevention1994 Accessed 29 January 2008. URL: http://www.ginasthma.org
   Google Scholar
• GreeningAPIndPWNorthfieldMon behalf of Allen and Hansburys Limited UK Study GroupAdded salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidLancet2007344219247913155
   PubMed Web of Science ®Google Scholar
• GreenstoneIRNi ChroininMNMasseVCombination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthmaCochrane Database Syst Rev20054CD00553316235409
   PubMedGoogle Scholar
• GoldmanMLawranceRAmbroseHEffect of Gly16Arg β2-adrenergic receptor variation on response to formoterol administered alone or in combination with budesonide in patients with moderate to severe persistent asthmaJ Allergy Clin Immunol2007119suppl 1S244 abstract 957
   Web of Science ®Google Scholar
• HancoxRJSearsMRTaylorDRPolymorphism of the β2-adrenoceptor and the response to long-term β2-agonist therapy in asthmaEur Respir J199811589939596107
   PubMed Web of Science ®Google Scholar
• HanselTTBenezetOKaféHA multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthmaClin Ther2006289062016860173
   PubMed Web of Science ®Google Scholar
• HinesRNMcCarverDGPharmacogenomics and the future of drug therapyPediatr Clin N Am200653591619
   PubMed Web of Science ®Google Scholar
• HoganSPFosterPSTanXRamsayAJMucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunityEur J Immunol199828413239521048
   PubMed Web of Science ®Google Scholar
• HolgateSTBraddingPSampsonAPLeukotriene antagonists and synthesis inhibitors: new directions in asthma therapyJ Allergy Clin Immunol1996981138765812
   PubMed Web of Science ®Google Scholar
• HolgateSTChuchalinAGHébertJEfficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthmaClin Exp Allergy200434632815080818
   PubMed Web of Science ®Google Scholar
• HorstMHejjaouiAHorstVDouble-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extractJ Allergy Clin Immunol199085460722406323
   PubMed Web of Science ®Google Scholar
• HumbertMBeasleyRAyresJBenefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEAllergy2005603091615679715
   PubMed Web of Science ®Google Scholar
• IsraelEDrazenJMLiggettSBfor the National Heart Lung and Blood Institute’s Asthma Clinical Research NetworkThe effect of polymorphisms of the β2-adrenergic receptor on the response to regular use of albuterol in asthmaAm J Respir Crit Care Med2000162758010903223
   PubMed Web of Science ®Google Scholar
• IsraelEChinchilliVMFordJGUse of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trialLancet200436415051215500895
   PubMed Web of Science ®Google Scholar
• JacobsenLNiggemannBDreborgSSpecific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT studyAllergy200762943817620073
   PubMed Web of Science ®Google Scholar
• KimS-HKimY-KParkHWAssociation between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthmaPharmacogenet Genomics20071729530417496729
   PubMed Web of Science ®Google Scholar
• KipsJManaging a variable diseasePulmon Pharmacol Therap20021548590
   PubMed Web of Science ®Google Scholar
• KipsJCO’ConnorBJLangleySJEffect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot studyAm J Respir Crit Care Med20031671655912649124
   PubMed Web of Science ®Google Scholar
• KlotsmanMYorkTPPillaiSGPharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukastPharmacogenet Genomics2007171899617460547
   PubMed Web of Science ®Google Scholar
• KolbMMartinGMedinaMGene therapy for pulmonary diseasesChest20061308798416963689
   PubMed Web of Science ®Google Scholar
• KohnoYMinoguchiKOdaNEffect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthmaJ Allergy Clin Immunol1998102927349847433
   PubMed Web of Science ®Google Scholar
• KunaPPetersMJManjraAIEffect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInt J Clin Pract2007617253617362472
   PubMed Web of Science ®Google Scholar
• LazarusSCBousheyHAFahyJVLong-acting ß2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma. A randomized controlled trialJAMA200128525839311368732
   PubMed Web of Science ®Google Scholar
• LazarusSCLeeTKempJPSafety and clinical efficacy of zileuton in patients with chronic asthmaAm J Mang Care199848418
   PubMed Web of Science ®Google Scholar
• LeckieMJten BrinkeAKhanJEffects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic responseLancet20003562144811191542
   PubMed Web of Science ®Google Scholar
• LemanskeRFSorknessCAMaugerEAInhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol. A randomized controlled trialJAMA2001285259460311368733
   PubMed Web of Science ®Google Scholar
• LimaJJTreatment heterogeneity in asthma: genetics of response to leukotriene modifiersMol Diagn Ther2007119710417397245
   PubMed Web of Science ®Google Scholar
• LimaJJZhangSGrantAInfluence of leukotriene pathway polymorphisms on response to montelukast in asthmaAm J Respir Crit Care Med20061733798516293801
   PubMed Web of Science ®Google Scholar
• MarcusPIncorporating anti-IgE (omalizumab) therapy into pulmonary medicine practice: Practice management implicationsChest20061294667416478867
   PubMed Web of Science ®Google Scholar
• MarottaAKlinnertMDPriceMRImpulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthmaJ Allergy Clin Immunol20031123172212897737
   PubMed Web of Science ®Google Scholar
• MathieuMGougatCJaffuelDThe glucocorticoid receptor gene as a candidate for gene therapy in asthmaGene Ther199962455210435109
   PubMed Web of Science ®Google Scholar
• MatsuoNShimodaTMitsutaKTacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissuesAnn Allergy Asthma Immunol200186671811428741
   PubMed Web of Science ®Google Scholar
• Menzies-GowAFlood-PagePSehmiRAnti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmaticsJ Allergy Clin Immunol20031117141912704348
   PubMed Web of Science ®Google Scholar
• MilgromHBergerWNayakATreatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)Pediatrics2001108E3611483846
   PubMed Web of Science ®Google Scholar
• MillerTPReevesMJLack of cost-effectiveness of omalizumabJ Allergy Clin Immunol20051154293015696113
   PubMed Web of Science ®Google Scholar
• Miller-LarssonASelroosOAdvances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting β2-agonistsCurr Pharm Des20061232617917020533
   PubMed Web of Science ®Google Scholar
• MoriceAHHochmuthLEkelundJComparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler® in adolescents and adults with asthmaPulm Pharmacol Ther2006 Epub ahead of press
   Web of Science ®Google Scholar
• MoriceAHPetersonSBeckmanOEfficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: A superiority and therapeutic equivalence studyPulm Pharmacol Ther2007a Epub ahead of press
   PubMed Web of Science ®Google Scholar
• MoriceAHPetersonSBeckmanOTherapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthmaInt J Clin Pract2007b6118748317887990
   PubMed Web of Science ®Google Scholar
• MovérareRVesterinenEMetsoTPollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrationsAnn Allergy Asthma Immunol2001863374211289336
   PubMed Web of Science ®Google Scholar
• NAEPP (National Asthma Education and Prevention Program)Full report of the Expert Panel: Guidelines for the Diagnosis and Management of Asthma (EPR-3)National Heart, Lung, and Blood Institute2006 Accessed 25 October 2007. URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
   Google Scholar
• NathanRARooklinASchoafLEfficacy and tolerability of fluticasone proprionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week studyClin Ther200728738516490581
   PubMed Web of Science ®Google Scholar
• NaveRFisherRZechKIn vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slicesBiopharm Drug Dispos20062719720716566061
   PubMed Web of Science ®Google Scholar
• NelsonHSWeissSTBleeckerERthe SMART study groupThe salmeterol multicenter asthma research trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterolChest2006129152616424409
   PubMed Web of Science ®Google Scholar
• NelsonHSLong-acting beta-agonists in adult asthma: evidence that these drugs are safePrim Care Respir J200615271716979380
   PubMedGoogle Scholar
• NoonanMRosenwasserLJMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trialDrugs20066622355417137405
   PubMed Web of Science ®Google Scholar
• NovembreEGalliELandiFCoseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitisJ Allergy Clin Immnol20041148517
   PubMed Web of Science ®Google Scholar
• O’ByrnePMBisgaardHGodardPPBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med20051711293615502112
   PubMed Web of Science ®Google Scholar
• PassalacquaGGuerraLPasqualiMEfficacy and safety of sublingual immunotherapyAnn Allergy Asthma Immunol20049331215281466
   PubMed Web of Science ®Google Scholar
• PauwelsRALöfdahlC-GPostmaDSfor the Formoterol and Corticosteroids, Establishing Therapy (FACET) International Study GroupEffect of inhaled formoterol and budesonide on exacerbations of asthmaN Engl J Med19973371405119358137
   PubMed Web of Science ®Google Scholar
• PauwelsRASearsMRCampbellMon behalf of the RELIEF Study InvestigatorsFormoterol as relief medication in asthma: a worldwide safety and effectiveness trialEur Resp J20032278794
   PubMed Web of Science ®Google Scholar
• PearlmanDSBergerWEKerwinEOnce-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthmaJ Allergy Clin Immunol200511612061216337447
   PubMed Web of Science ®Google Scholar
• PearlmanDSPedenDCondemiJJEfficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthmaJ Asthma20044179780615641629
   PubMed Web of Science ®Google Scholar
• PetskyHLKynastonJATurnerCTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev200718CD00560317443604
   PubMed Web of Science ®Google Scholar
• Pulmicort Flexhaler 180 mcg and 90 mcg [package insert]2007Wilmington, DEAstraZeneca
   Google Scholar
• RabeKFAtienzaTMagyarPEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised, controlled, double-blind studyLancet20063687445316935685
   PubMed Web of Science ®Google Scholar
• RabyBAHwangE-SVan SteenKT-bet polymorphisms are associated with asthma and airway hyperresponsivenessAm J Respir Crit Care Med2006173647016179640
   PubMed Web of Science ®Google Scholar
• RouhaniFNMeitinCAKalerMEffect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammationRespir Med20059911758216085220
   PubMed Web of Science ®Google Scholar
• SaekiSMatsuseHKondoYEffects of antiasthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patientsJ Allergy Clin Immunol20041145384415356554
   PubMed Web of Science ®Google Scholar
• Schering-Plough CorporationSchering-Plough announces global agreement with Novartis to develop once-daily combination therapy for asthma and COPD [news release]2006814 Accessed 29 June 2007. URL: http://www.schering-plough.com/schering_plough/news/release.jsp?releaseID=895303
   Google Scholar
• SearsMOttossonARadnerFSafety of formoterol in asthma trials [abstract]2007Presented at the European Respiratory Society Annual CongressSeptember 15–19, 2007Stockholm, Sweden Abstract number 1586
   Google Scholar
• SelroosOSome aspects on comparative efficacy studies with inhaled corticosteroids in asthmaCurr Drug Ther200725754
   Google Scholar
• SinDDManJSharpeHPharmacological management to reduce exacerbations in adults with asthma. A systematic review and meta-analysisJAMA20042923677615265853
   PubMed Web of Science ®Google Scholar
• SilkoffPECarlsonMBourkeTThe Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthmaJ Allergy Clin Immunol200411412415615536442
   PubMed Web of Science ®Google Scholar
• SolèrMMatzJTownleyRThe anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsEur Respir J2001182546111529281
   PubMed Web of Science ®Google Scholar
• SopoSMMacchiaioloMZorziGSublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literatureArch Dis Child2004896202415210490
   PubMed Web of Science ®Google Scholar
• StrunkRCBloombergGROmalizumab for asthmaN Engl J Med200635426899516790701
   PubMed Web of Science ®Google Scholar
• SzeflerSJPhillipsBRMartinezFDfor the Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood InstituteCharacterization of within-subject responses to fluticasone and montelukast in childhood asthmaJ Allergy Clin Immunol20051152334215696076
   PubMed Web of Science ®Google Scholar
• TantisiraKGHwangESRabyBA TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroidsPNAS20041011809910415604153
   PubMed Web of Science ®Google Scholar
• TattersfieldAELöfdahlC-GPostmaDSComparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trialLancet20013572576111214127
   PubMed Web of Science ®Google Scholar
• TaylorDRDrazenJMHerbisonGPAsthma exacerbations during long term β agonist use: influence of β2 adrenoceptor polymorphismThorax200055762710950895
   PubMed Web of Science ®Google Scholar
• van der WoudeHJBoorsmaMBergqvistPBFBudesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstrictionPulm Pharmacol Ther200417899515123230
   PubMed Web of Science ®Google Scholar
• VogelmeierCD’UrzoAPauwelsRBudesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?Eur Respir J2005268192816264042
   PubMed Web of Science ®Google Scholar
• WaldersNKopelSJKoinis-MitchellDPatterns of quick-relief and long-term controller medication use in pediatric asthmaJ Pediatr20051461778215689902
   PubMed Web of Science ®Google Scholar
• WangLCLeeJHYangYHNew biological approaches in asthma: DNA-based therapyCurr Med Chem20071416071817584068
   PubMed Web of Science ®Google Scholar
• WechslerMEManaging asthma in the 21st century: role of pharmacogeneticsPediatr Ann200635660662664916999299
   PubMed Web of Science ®Google Scholar
• WechslerMELehmanELazarusSCfor the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Networkβ-adrenergic receptor polymorphisms and response to salmeterolAm J Respir Crit Care Med20061735192616322642
   PubMed Web of Science ®Google Scholar
• WechslerMEIsraelEHow pharmacogenomics will play a role in the management of asthmaAm J Respir Crit Care Med200517212815778484
   PubMed Web of Science ®Google Scholar
• WenzelSEAntileukotriene drugs in the management of asthmaJAMA1998280206899875862
   PubMed Web of Science ®Google Scholar
• WilliamsLKPladevallMHugoXRelationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthmaJ Allergy Clin Immunol200411412889315577825
   PubMed Web of Science ®Google Scholar